Clinical Research Collaboration Agreement Between Awardee and Study SiteClinical Research Collaboration Agreement • October 19th, 2023
This Clinical Research Collaboration Agreement (“Agreement”), is by and between (“Awardee”), a [***drafting note- insert type of organization here, i.e., health care organization***] with a place of business at , and (“Study Site),
AMENDMENT TO CLINICAL RESEARCH COLLABORATION AGREEMENTClinical Research Collaboration Agreement • April 11th, 2014 • Cytodyn Inc • Pharmaceutical preparations
This Amendment (“Amendment”), effective as of the last signature below, hereby amends the Clinical Research Collaboration Agreement (“Agreement”), which was effective November 15, 2012, by and between CYTODYN INC., a Colorado corporation principally located at 1111 Main Street, Suite 660, Vancouver, Washington 98660 (“Company”), and Philadelphia Health & Education Corporation d/b/a DREXEL UNIVERSITY COLLEGE OF MEDICINE, having an office located at 1601 Cherry Street, Suite 10627, Philadelphia, PA 19102 (“Institution”).
CLINICAL RESEARCH COLLABORATION AGREEMENTClinical Research Collaboration Agreement • August 29th, 2013 • Cytodyn Inc • Pharmaceutical preparations • Pennsylvania
This Clinical Research Collaboration Agreement, effective on the last date of signature (“Effective Date”), is by and between CytoDyn, Inc., a Colorado, Corporation principally located at Lake Oswego, Oregon, (“Company”) and Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine, a 501(c)(3) Pennsylvania, nonprofit corporation principally located at 245 N. 15th Street, Philadelphia, PA 19102 (“Institution”). Company and Institution shall herein be individually referred to as “Party” and collectively referred to as “Parties.”
